“…As antiplatelet and antithrombotic therapies, phosphodiesterase inhibitors and acetylsalicylic acid were successfully studied and have been shown to induce organ protection upon intestinal I/R [111,112]. In addition, a myriad number of approaches implemented the application of antibodies directed against the adhesion molecules which are involved in the distinct cellular crosstalk between leukocytes, platelets, T cells, and endothelial cells [42,113,114]. For example, disruption of P-selectin signaling either via blockade of the molecule or the genetic deficiency of P-selectin modulates cell trafficking and results in improved outcomes after mouse warm intestinal I/R [115].…”